Activators and Inhibitors of NRF2: A Review of Their Potential for Clinical Development
Top Cited Papers
Open Access
- 14 July 2019
- journal article
- review article
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2019, 1-20
Abstract
The transcription factor NRF2 (nuclear factor erythroid 2-related factor 2) triggers the first line of homeostatic responses against a plethora of environmental or endogenous deviations in redox metabolism, proteostasis, inflammation, etc. Therefore, pharmacological activation of NRF2 is a promising therapeutic approach for several chronic diseases that are underlined by oxidative stress and inflammation, such as neurodegenerative, cardiovascular, and metabolic diseases. A particular case is cancer, where NRF2 confers a survival advantage to constituted tumors, and therefore, NRF2 inhibition is desired. This review describes the electrophilic and nonelectrophilic NRF2 activators with clinical projection in various chronic diseases. We also analyze the status of NRF2 inhibitors, which at this time provide proof of concept for blocking NRF2 activity in cancer therapy.Keywords
Funding Information
- European Regional Development Fund (P_37_732/2016, B2017/BMD-3827, SAF2016-76520-R)
- Autonomous Community of Madrid (P_37_732/2016, B2017/BMD-3827, SAF2016-76520-R)
- Ministerio de Economía y Competitividad (P_37_732/2016, B2017/BMD-3827, SAF2016-76520-R)
This publication has 164 references indexed in Scilit:
- Anti-inflammatory Effect of a Cell-Penetrating Peptide Targeting the Nrf2/Keap1 InteractionACS Medicinal Chemistry Letters, 2012
- Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesisNature, 2011
- Electrophilic Nitro-fatty Acids Activate NRF2 by a KEAP1 Cysteine 151-independent MechanismJournal of Biological Chemistry, 2011
- Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanismProceedings of the National Academy of Sciences, 2011
- GSK3 signalling in neural developmentNature Reviews Neuroscience, 2010
- p62/SQSTM1 Is a Target Gene for Transcription Factor NRF2 and Creates a Positive Feedback Loop by Inducing Antioxidant Response Element-driven Gene TranscriptionJournal of Biological Chemistry, 2010
- Activation of NRF2 by Nitrosative Agents and H2O2 Involves KEAP1 Disulfide FormationJournal of Biological Chemistry, 2010
- Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancyProceedings of the National Academy of Sciences, 2008
- Identification of retinoic acid as an inhibitor of transcription factor Nrf2 through activation of retinoic acid receptor alphaProceedings of the National Academy of Sciences, 2007
- Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signalingThe EMBO Journal, 2006